Keyphrases
Genetic Modification
100%
Brain Tumor
100%
Promoter Methylation
100%
O6-methylguanine-DNA Methyltransferase
100%
Glioma
30%
Protein Expression
23%
Immunohistochemistry
23%
Hypermethylation
23%
Oligodendroglioma
23%
Western Blotting
15%
Prognostic Significance
15%
Isocitrate Dehydrogenase 1 (IDH1)
15%
Glial Tumors
15%
IDH2 mutation
15%
Glioblastoma multiforme Cells
15%
Tumor
7%
Western Blot Analysis
7%
TP53 mutation
7%
Prognostic Marker
7%
Chemotherapy
7%
Protein Level
7%
Malignancy Grade
7%
Histological Grade
7%
Quantitative Methylation-specific PCR (Q-MSP)
7%
Capillary Electrophoresis
7%
Low-grade Tumor
7%
Primitive Neuroectodermal Tumor
7%
1p/19q Codeletion
7%
EGFR Amplification
7%
Low-grade Glioma
7%
Human Brain Tumor
7%
1p Deletion
7%
Astrocytic Glioma
7%
Medicine and Dentistry
Gene Mutation
100%
Promoter Region
100%
Methylated DNA Protein Cysteine Methyltransferase
100%
Intracranial Tumor
100%
Ganglioglioma
61%
Protein Expression
23%
Immunohistochemistry
23%
Oligodendroglioma
23%
Western Blotting
23%
Neoplasm
15%
Glioblastoma Multiforme Cell Line
15%
Cancer
7%
Methylation
7%
Capillary Electrophoresis
7%
Epidermal Growth Factor Receptor
7%
Primitive Neuroectodermal Tumor
7%
Chemotherapy
7%
Neuroscience
Promoter Region
100%
Gene Mutation
100%
Methylated DNA Protein Cysteine Methyltransferase
100%
Intracranial Tumor
100%
Immunohistochemistry
23%
Protein Expression
23%
Oligodendroglioma
23%
Western Blotting
23%
Cell Line
15%
Glioblastoma Multiforme
15%
IDH2
15%
Epidermal Growth Factor Receptor
7%
Primitive Neuroectodermal Tumor
7%
TP53
7%
Low-Grade Glioma
7%
Capillary Electrophoresis
7%
Methylation
7%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Gene Mutation
100%
DNA Methyltransferase
100%
6-O-Methylguanine
100%
Protein Expression
23%
Western Blotting
23%
IDH1
15%
IDH2
15%
Epidermal Growth Factor Receptor
7%
Methylation
7%
Capillary Electrophoresis
7%